Allopurinol is a medicine used to help lower high uric acid levels in your blood. High uric acid can lead to painful gout attacks. It works by reducing the amount of uric acid your body makes. It's often taken daily, sometimes with food, to keep uric acid levels stable.
Every report comes from a Lived member, sent anonymously.
Have you tried Allopurinol for Gout?
Allopurinol, also sold under the brand name Zyloprim, is a prescription tablet that lowers the amount of uric acid in the body. Its main use is long-term treatment of gout, a form of arthritis in which uric acid builds up and forms crystals in and around joints, causing sudden attacks of pain, swelling and redness. Over time, these crystals can also form lumps under the skin called tophi and damage joints. Allopurinol prevents gout attacks over time; it does not relieve an attack that has already started. Rheumatology guidelines recommend it as the usual first choice for lowering uric acid in people with gout, including people with chronic kidney disease. Treatment is typically advised for people who have tophi, joint damage from gout, or two or more attacks a year. Allopurinol is also used to prevent dangerous rises in uric acid in adults and children receiving treatment for leukemia, lymphoma and other cancers, when tumor cells break down quickly and release large amounts of it. It also helps prevent repeat calcium oxalate kidney stones in adults whose urine contains a lot of uric acid despite diet and fluid changes. It is not recommended for people who simply have a high uric acid level on a blood test but no gout, stones or cancer treatment.
Uric acid is the end product of breaking down purines, natural substances found in the body's own cells and in many foods. An enzyme called xanthine oxidase carries out the last two steps that turn purines into uric acid. Allopurinol, and the longer-lasting substance the body converts it into, block this enzyme, so less uric acid is made. With less uric acid in the blood, existing crystals in the joints slowly dissolve and new ones are less likely to form. This is why allopurinol prevents attacks and shrinks tophi gradually rather than working within days.
Allopurinol is taken by mouth, usually once a day, and it tends to be easier on the stomach when taken after a meal. Doses above 300 mg a day are split into two or more doses. Before starting allopurinol for gout, the prescriber usually checks uric acid, blood counts, and liver and kidney function. For gout, treatment starts at a low dose, commonly 100 mg a day, and lower still for people with reduced kidney function. The prescriber then raises the dose step by step, no more often than once a week, and rechecks the blood uric acid level each time. The usual goal is a level of 6 mg/dL (milligrams per deciliter) or lower, which is low enough for crystals to dissolve. Many people need more than 300 mg a day to reach that target, up to a maximum of 800 mg a day. Starting low and increasing slowly lowers the risk of both early flares and serious reactions. Drinking plenty of fluids, about 2 liters (roughly 8 cups) a day for adults, helps protect the kidneys. If a dose is missed, take the next one as usual rather than doubling up. In cancer care, allopurinol is usually started a day or two before chemotherapy and dosed by the cancer team.
Rash is the most common side effect. Nausea, diarrhea and mild changes in liver blood tests also occur, and some people feel drowsy or dizzy when starting or increasing the dose, so it is sensible to see how it affects you before driving. A small number of people, roughly 5 in 10,000, develop a severe allergic-type reaction that affects the skin and sometimes internal organs, such as the liver or kidneys. These reactions, which include Stevens-Johnson syndrome, are serious and can be fatal. They usually begin within the first few months. Because a mild rash can be the first sign, stop allopurinol and contact your prescriber right away if any new rash appears. A rash with fever, blistering or peeling skin, sores in the mouth or eyes, or swelling of the lips or face needs emergency care. Someone who has had this kind of reaction should not take allopurinol again. Less often, allopurinol affects the liver or the bone marrow, which makes blood cells. Tell your care team about yellowing of the skin or eyes, persistent itching or loss of appetite, and about frequent infections, fever, unusual bruising or bleeding, or marked tiredness.
A gene variant called HLA-B*58:01 raises the risk of the severe skin reaction. It is more common in people of Han Chinese, Korean, Thai, African and Native Hawaiian or Pacific Islander ancestry, and a blood test for it may be offered before starting. Kidney disease and taking a thiazide diuretic (a water pill such as hydrochlorothiazide) also raise the risk, and people with reduced kidney function need lower doses and closer monitoring. The most important interaction is with azathioprine and mercaptopurine, medicines used for autoimmune conditions, organ transplants and some leukemias. Allopurinol blocks their breakdown, so their doses must be cut to roughly a quarter to a third of usual, or blood counts can fall dangerously. Allopurinol can also strengthen the effect of warfarin, a blood thinner, so INR (a clotting blood test) is checked more often. The antibiotics ampicillin and amoxicillin make rashes more likely. Allopurinol should not be combined with pegloticase (Krystexxa), an infused gout treatment, or with the chemotherapy pill capecitabine. Animal studies suggest possible harm to a developing baby, though limited human data have not shown a clear pattern. Anyone pregnant or planning pregnancy should discuss whether to continue. The label advises against breastfeeding during treatment and for one week after the last dose.
Gout attacks often become more frequent, not less, in the first few months. As uric acid falls, crystals loosen from the joints and can trigger flares. To prevent this, a prescriber usually adds colchicine or an anti-inflammatory medicine for at least three to six months. If a flare happens, keep taking allopurinol and treat the flare separately; stopping would undo the progress. It can take several months to reach the target uric acid level and longer for attacks to become rare and for tophi to shrink. Blood tests are repeated during dose increases, then less often once the level is stable. For most people with gout, allopurinol is a long-term treatment. It controls uric acid but does not cure the underlying tendency, so stopping usually lets levels rise again. Keep taking it when you feel well, and discuss any plan to stop with the prescriber.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Allopurinol, what you've noticed, or ask the community a question.